Leiden University researchers have developed the first-ever ‘dengue-on-a-chip’ model, using organ-on-a-chip technology to simulate the human body’s response to dengue infection, particularly focusing on hemorrhagic shock. This innovative tool offers a more ethical and cost-effective alternative to animal testing, aiding in the study of disease progression and the development of targeted treatments for the growing global health threat posed by dengue.

Leiden Bio Science Park joined Bètabanenmarkt 2025 to connect science students with top employers in the life sciences sector. The event offered hands-on career support and showcased opportunities across research, industry, and entrepreneurship.

A study from Leiden University reveals that daily probiotic intake can help alleviate negative emotions like anxiety, stress, and fatigue, with participants reporting mood improvements after two weeks of consuming Lactobacillus and Bifidobacterium strains.

To help address the growing need for well-trained production personnel in the Life Sciences industry, Talentmark and Biotech Training Facility (BTF)...

On April 8, 2025, six academics from Leiden University were officially appointed as Medical Delta Professors, marking a significant milestone in interdisciplinary collaboration aimed at advancing sustainable healthcare solutions. The newly appointed professors bring diverse expertise from fields such as architecture, neuropsychology, epidemiology, and design, all contributing to innovations at the intersection of technology and healthcare.

From 6–9 May 2025, the Netherlands Embassy in Seoul, in collaboration with the Netherlands Enterprise Agency (RVO), is organising a trade mission to...

Leyden Laboratories B.V. has unveiled promising results from its study on intranasal antibody therapy, CR9114, which demonstrates broad-spectrum protection against influenza viruses, including A, B, C, and D strains. The research highlights the benefits of delivering antibodies directly to the nasal mucosa, offering a novel, low-dose approach to combating respiratory infections with a unique Fc-independent mechanism of action.

Secure Your Spot in the Dutch Innovator Village at HLTH Europe 2025! Are you ready to present your health tech innovation to the world at HLTH...

Leiden Bio Science Park hosted a European Commission delegation at Johnson & Johnson to discuss international trade and its impact on the Life Sciences sector. The visit showcased the Park’s innovative ecosystem and strong academic-industry collaboration.